0 CHECKOUT

PRODUCT FILTERS

REGION

6
5
5
5
1

COUNTRY

1
1
1
1
1

CATEGORIES

  • 8
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

0
0
2
11

PUBLISHED

0
1
1
11

PRODUCT TYPE

11

Search for: "YM BioSciences Inc.-Therapeutic Competitors Report"

Essential Thrombocythemia - Pipeline Review, H1 2016

Essential Thrombocythemia - Pipeline Review, H1 2016 Summary ‘Essential Thrombocythemia - Pipeline Review, H1 2016’, provides an overview of the Essential Thrombocythemia pipeline landscape. The...

Published:  April 2016
Price:  From

Essential Thrombocythemia - Pipeline Review, H1 2015

Essential Thrombocythemia - Pipeline Review, H1 2015 Summary This, ‘Essential Thrombocythemia - Pipeline Review, H1 2015’, provides an overview of the Essential Thrombocythemia’s therapeutic pipeline. This...

Published:  March 2015
Price:  From

Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020” The report is an essential...

Published:  December 2010
Price:  From

Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020” The report is an essential...

Published:  December 2010
Price:  From

Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020” is an essential source...

Published:  December 2010
Price:  From

Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020” is an essential source of information...

Published:  December 2010
Price:  From

Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020” is an essential source...

Published:  December 2010
Price:  From

Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020” The report is an...

Published:  November 2010
Price:  From

Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Brazil, Russia, India and China (BRIC) Drug Forecasts and Treatment Analysis...

Published:  December 2010
Price:  From

Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020” is an essential source of information...

Published:  November 2010
Price:  From

The Emerging Cancer Vaccine Market, 2nd Edition

Propelled by advances in molecular biology, the cancer vaccine industry is poised for unprecedented growth. This second edition of Kalorama’s groundbreaking 2003 study completely updates the market...

Published:  November 2006
Price:  From
Loading Indicator

Our Clients

  • Ikea Systems B.V.
  • GlaxoSmithKline PLC
  • BT Group PLC.
  • Philips N.V.
  • BSH Home Appliances Ltd
  • Foreign & Commonwealth Office